{"altmetric_id":20559900,"counts":{"readers":{"mendeley":3,"citeulike":0,"connotea":0},"total":{"posts_count":1},"policy":{"unique_users_count":1,"unique_users":["nice"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa4e83cf058f610002280","authors":["Oberhoff, C.","Neri, B.","Amadori, D.","Petry, K. U.","Gamucci, T.","Rebmann, U.","Nowrousian, M. R.","Voigtmann, R.","Monfardini, S.","Armand, J. P.","Herrmann, R.","Netter-Pinon, J.","Tubiana-Mathieu, N.","Zwierzina, H."],"doi":"10.1023\/a:1008296622469","first_seen_on":"2017-05-26T10:46:41+00:00","issns":["09237534","0923-7534"],"journal":"Annals of Oncology","last_mentioned_on":1397520000,"links":["http:\/\/dx.doi.org\/10.1023\/A:1008296622469"],"pdf_url":"https:\/\/academic.oup.com\/annonc\/article-pdf\/9\/3\/255\/7014149\/9-3-255.pdf","pubdate":"1998-03-01T00:00:00+00:00","publisher":"Oxford University Press","scopus_subjects":["Medicine","Health Sciences"],"title":"Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: A randomized, controlled study","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/recombinant-human-erythropoietin-treatment-chemotherapy-induced-anemia-prevention-transfusion-requir"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":8087128,"mean":6.8806386287663,"rank":2037103,"this_scored_higher_than_pct":61,"this_scored_higher_than":4944420,"rank_type":"exact","sample_size":8087128,"percentile":61},"similar_age_3m":{"total_number_of_other_articles":218975,"mean":12.050475572442,"rank":71031,"this_scored_higher_than_pct":66,"this_scored_higher_than":145724,"rank_type":"exact","sample_size":218975,"percentile":66},"this_journal":{"total_number_of_other_articles":3573,"mean":9.5282441209406,"rank":1397,"this_scored_higher_than_pct":48,"this_scored_higher_than":1749,"rank_type":"exact","sample_size":3573,"percentile":48},"similar_age_this_journal_3m":{"total_number_of_other_articles":118,"mean":25.093282051282,"rank":68,"this_scored_higher_than_pct":41,"this_scored_higher_than":49,"rank_type":"exact","sample_size":118,"percentile":41}}},"demographics":{"users":{"mendeley":{"by_status":{"Professor":2,"Researcher":1},"by_discipline":{"Medicine and Dentistry":1,"Unspecified":2}}}},"posts":{"policy":[{"title":"Erythropoiesis\u2011stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy: Anaemia (cancer-treatment induced) - erythropoiesis-stimulating agents (epoetin and darbepoetin) (inc rev TA142): evaluation report","url":"https:\/\/www.nice.org.uk\/guidance\/TA323\/documents\/anaemia-cancertreatment-induced-erythropoiesisstimulating-agents-epoetin-and-darbepoetin-inc-rev-ta142-evaluation-report2","license":"public","citation_ids":[20559817,542389,20543235,20559824,20559830,20559833,20559837,20559842,20559844,20559852,20559858,20559863,20559868,20559871,20559877,20559880,20328340,20559883,20559886,20559889,20559892,20559895,20559900,20559910,20559935,20559944,7853288,20559954,20559961,20559964,20559966,1068651,20559995,20559999,20560005,20560009,20560010,20560014,5730013,20560022,20520143,20560026,20560029,2826808,6091477,17960669,20560037,16024508,20560042,20560044,20560046,20560052,6079023,20560058,20560065,227780,20560073,20560077,1233878,20560085,4233141,20560094,20560098,20560103,20560105,20560110,5785950,20560116,20560117,3077914,817113,5793332,20560130,20560133,20560137,16685368,20560141,5582772,20560150,20560155,20560159,20560160,20560164,20560169,20560173,20560179,17965062,20560187,20560192,5314511,20560196,20560199,20560203,20560206,20560210,20560213,20560217,20560220,20560222,5785953,20560227,20560229,20560231,20558187,16685370,210520,5606480,20560242,20560246,5754844,5728047,20560256,210508,228589,20560264,20560268,20560273,20560275,20560278,20560281,17910642,537576,20560289,20560292,20560297,4323630,20560301,20560322,20560325,20560329,20560334,20560343,20560352,20560356,20560359,20560364,20560367,20560372,20560375,20560378,20560380,20560383,20560386,20560391,20560396,20560401,20560405,20560409,20560412,20560420,20560425,16685367,20560431,20560434,20560441,20560445,20560449,20560549,20560555,20560562,17903608,20560657,20560665,20560670,20560675,20560678,20560680,20560683,20560685,20560690,20560694,20560701,20560706,20560712,20560718,20560720,20560725,1428849,4273683,20560746,20560750,20560752,5778068,7742482,20560764,20560769,20520149,20560773,20560779,20560787,20560791,20560800,20560806,20560814,20560818,20560823,20560825,20560828,8064455,17909340,20560838,20560840,5381355,20560853,20560862,20560865,20560869,20560875,20560883,173734,20560890,20560920,20560927,5581930,20559817,20560014],"posted_on":"2014-04-15T00:00:00+00:00","source":{"name":"National Institute for Health and Care Excellence","description":"The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.","geo":{"country":"GB"}},"page_url":"https:\/\/www.nice.org.uk\/guidance\/ta323\/evidence","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-1688c9323bc1c873924cb8dfd25b2b32ac683222fb2139083b9e2501db6832aa.jpg"}}]}}